FDA NDC
Acamprosate Calcium
This name is from the loaded FDA file.
Source: FDA NDC Directory, live from openFDA. Publisher page
- NDC
- 0378-6333
- Proprietary name
- Acamprosate Calcium
- Nonproprietary name
- acamprosate calcium enteric-coated
- Labeler
- Mylan Pharmaceuticals Inc.
- Dosage form
- TABLET, DELAYED RELEASE
- Strength
- 333 mg/1
Run it in Rivvi
Which 2027 plans near you dropped or restricted acamprosate calcium enteric-coated?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan, from the CMS Part D files.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.